Functional plasma-sprayed hydroxylapatite coatings for medical application: Clinical performance requirements and key property enhancement

2021 ◽  
Vol 39 (5) ◽  
pp. 050801
Author(s):  
Robert B. Heimann
1999 ◽  
Vol 10 (4) ◽  
pp. 245-256 ◽  
Author(s):  
Ann V. Burgess ◽  
Brooks J. Story ◽  
Danny La ◽  
William R. Wagner ◽  
John P. LeGeros

1993 ◽  
Vol 12 (1) ◽  
pp. 31-39 ◽  
Author(s):  
R.Y. Whitehead ◽  
L.C. Lucas ◽  
W.R. Lacefield

2001 ◽  
Vol 58 (5) ◽  
pp. 570-592 ◽  
Author(s):  
Limin Sun ◽  
Christopher C. Berndt ◽  
Karlis A. Gross ◽  
Ahmet Kucuk

2016 ◽  
Vol 6 (4) ◽  
Author(s):  
Andrew McCabe ◽  
Martin Pickford ◽  
James Shawcross

Thermal plasma sprayed coatings are designed to improve both the biocompatibility and durability of implantable medical devices, and include pure titanium, cobalt/chrome alloy and hydroxyapatite.  Coated joint replacements have now been in continuous clinical use for thirty years and are applied to products manufactured or used in Europe, North America, South America, Africa, Asia and Australasia. Prostheses incorporating such coatings have been successfully implanted into several million of patients worldwide and to date there have been very few reports of any failure of an implant which could be attributed to problems with, or failure of, the coating. This paper summarises the early history of cementless prostheses and subsequent development, specification, validation, regulatory requirements and clinical performance of thermal plasma spray coatings provided by Accentus Medical.


2019 ◽  
Vol 20 (7) ◽  
pp. 1763 ◽  
Author(s):  
Tariq O. Abbas ◽  
Huseyin C. Yalcin ◽  
Cristian P. Pennisi

Several congenital and acquired conditions may result in severe narrowing of the urethra in men, which represent an ongoing surgical challenge and a significant burden on both health and quality of life. In the field of urethral reconstruction, tissue engineering has emerged as a promising alternative to overcome some of the limitations associated with autologous tissue grafts. In this direction, preclinical as well as clinical studies, have shown that degradable scaffolds are able to restore the normal urethral architecture, supporting neo-vascularization and stratification of the tissue. While a wide variety of degradable biomaterials are under scrutiny, such as decellularized matrices, natural, and synthetic polymers, the search for scaffold materials that could fulfill the clinical performance requirements continues. In this article, we discuss the design requirements of the scaffold that appear to be crucial to better resemble the structural, physical, and biological properties of the native urethra and are expected to support an adequate recovery of the urethral function. In this context, we review the biological performance of the degradable polymers currently applied for urethral reconstruction and outline the perspectives on novel functional polymers, which could find application in the design of customized urethral constructs.


Sign in / Sign up

Export Citation Format

Share Document